Serologic diagnosis of NMOPatrick Waters, Sean J. Pittock, Vanda A. Lennon et al.|Neurology|2012Cited by 526
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot studySean J. Pittock, Dean M. Wingerchuk, Vanda A. Lennon et al.|The Lancet Neurology|2013Cited by 394
Epidemiology of aquaporin‐4 autoimmunity and neuromyelitis optica spectrumEoin P. Flanagan, Sean J. Pittock, Philippe Cabre et al.|Annals of Neurology|2016Cited by 339
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth editionHans‐Christoph Diener, Jay Mandrekar, Cristina Tassorelli et al.|Cephalalgia|2019Cited by 235
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSDJiraporn Jitprapaikulsan, Sean J. Pittock, James P. Fryer et al.|Neurology Neuroimmunology & Neuroinflammation|2020Cited by 65